- Record: found
- Abstract: not found
- Article: not found
Interim analysis of zuma-5: a phase 2 study of axicabtagene ciloleucel (AXI-cel) in patients with relapsed/refractory indolent non-Hodgkin lymphoma
Read this article at
ScienceOpen
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.